Molecular Pharmacology Program Member David Scheinberg focuses on the discovery and development of novel, specific immunotherapeutic agents and targeted nanodevices for cancer therapy.

Learn how high-intensity focused ultrasound (HIFU) can help some men with prostate cancer avoid surgery or radiation.

Dr. Yueming Li studies disease mechanism of Cancer and Alzheimer’s, with the goal of developing novel therapeutics for clinical use.

Pharmacologist Neal Rosen focuses on understanding biochemical mechanisms underlying phenotypes caused by tyrosine kinase activation in epithelial tumors and developing new therapeutic strategies.

If you think women are the only people who get cancers caused by the human papillomavirus (HPV), think again. These cancers are on the rise in men.

Animal model research from MSK has shown for the first time that fasting can reprogram the metabolism of natural killer cells, helping them to survive in the harsh environment in and around tumors, ...

This information explains what to expect before, during, and after verapamil injections (shots) for treatment of Peyronie’s disease.

Scientists at the Sloan Kettering Institute have discovered that the ability of cancers to metastasize to other organs is dependent upon their ability to coopt natural wound-healing pathways. The ...

Esta información le ayudará a prepararse para su procedimiento de colocación de marcadores de referencia en la próstata, ya que le explica qué esperar antes, durante y después de su procedimiento. Se ...

The immune system can clearly recognize cancer cells as different, yet often it is unable to stop them from growing. Scientists are trying to understand why.

Amazon Web Services (AWS), an Amazon.com, Inc. company (NASDAQ: AMZN) and Memorial Sloan Kettering Cancer Center (MSK), a leading global cancer center, today announced a collaboration harnessing the ...

Like all cells, cancer cells need nutrients to grow. Sugar is one important fuel, but it’s far from cancer’s only requirement. Current research is aimed at targeting cancer’s dependence on the amino ...